Open access
Sep 2026
Mechanistic study of cycloastragenol in improving heart failure by regulating PI3K/AKT/mTOR signaling and ferroptosis.
CAG improved HF-related myocardial injury and myocardial remodeling by restoring PI3K/AKT/mTOR signaling activity and inhibiting ferroptosis-related processes, suggesting that CAG may be a potential therapeutic agent for HF.
Shu-Bo Qi, Dong-Sheng Wei, Peng-Yu Pan et al.
· Toxicology and Applied Pharm... · 0 citations